OSCP1 and neoplasm: Consequently, we propose to structure a tumor-targeting, pH-stimulated drug/shRNA codelivery system (AR-NADR) (Fig. 2) that comprises two functional modules, including the core of the nanocarrier system, that is, NLS-modified Ag-MOF (NA) loaded with DDP (D) and NOR1 shRNA (R).